⌘K

Login Start Free

Home/Filings/4/0001209191-23-055408

4//SEC Filing

Akdamar Erol R 4

Accession 0001209191-23-055408

CIK 0000860730other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 5:37 PM ET

Size

16.2 KB

Accession

0001209191-23-055408

Insider Transaction Report

Form 4

Period: 2023-11-13

HCA Healthcare, Inc.HCA

Group President

Transactions

Exercise/Conversion
Common Stock
2023-11-13$47.97/sh+26,825$1,286,795→ 26,825 total
Tax Payment
Common Stock
2023-11-13$229.99/sh−13,951$3,208,590→ 12,874 total
Exercise/Conversion
Stock Appreciation Right
2023-11-13−14,500→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (14,500 underlying)
Exercise/Conversion
Stock Appreciation Right
2023-11-13−12,325→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (12,325 underlying)

Holdings

Common Stock
(indirect: By Trust)
42,484
Common Stock
(indirect: By LLC)
60,000

Footnotes (2)

[F1]The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
[F2]The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

Documents

2 files

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1

filerCIK 0001957739

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 5:37 PM ET
Size: 16.2 KB

View on SEC.gov